Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.7K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.7K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.6K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.0K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.3K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.3K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spindle neurons in human cortex possess distinctive firing properties and transcriptomic signatures.

Nature communications·2026
Same author

MUS-HGFC: Inferring miRNA-disease associations with multi-scale hypergraph representations.

International journal of biological macromolecules·2026
Same author

FluNexus: A versatile web platform for antigenic prediction and visualization of influenza A viruses.

iMeta·2026
Same author

DiffuST: a Latent Diffusion Model for Spatial Transcriptomics Denoising.

IEEE transactions on computational biology and bioinformatics·2026
Same author

Embedding multilayer RNA networks for lncRNA-miRNA interaction prediction via LMI-MHGAT.

BMC biology·2026
Same author

DualGPT-AB: a dual-stage generative optimization framework for therapeutic antibody design.

Nature computational science·2026

Related Experiment Video

Updated: Dec 8, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.4K

A learning-based method for drug-target interaction prediction based on feature representation learning and deep

Jiajie Peng1,2, Jingyi Li1,2, Xuequn Shang3,4

  • 1The School of Computer Science, Northwestern Polytechnical University, Xian, 710072, China.

BMC Bioinformatics
|September 17, 2020
PubMed
Summary

This study introduces DTI-CNN, a novel computational method for predicting drug-target interactions. DTI-CNN significantly improves drug discovery efficiency by accurately identifying potential drug-target relationships, reducing costs and time.

Keywords:
Convolutional neural networkDTIs predictionFeature representation learning

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Related Experiment Videos

Last Updated: Dec 8, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.4K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Area of Science:

  • Bioinformatics
  • Computational Chemistry
  • Drug Discovery

Background:

  • Drug-target interaction (DTI) prediction is crucial for efficient drug discovery.
  • Traditional experimental methods are costly and time-consuming.
  • Computational prediction of DTIs offers a cost-effective and time-saving alternative.

Purpose of the Study:

  • To develop a novel computational method for predicting drug-target interactions.
  • To enhance the accuracy and efficiency of drug discovery processes.
  • To reduce the experimental costs and time associated with identifying new drug candidates.

Main Methods:

  • Feature extraction from heterogeneous networks using Jaccard similarity and random walk.
  • Dimensionality reduction and feature selection via denoising autoencoders.
  • Development of a convolutional neural network (CNN) for DTI prediction (DTI-CNN).

Main Results:

  • The DTI-CNN model achieved an average AUROC score of 0.9416 and AUPR score of 0.9499.
  • DTI-CNN demonstrated superior performance compared to three existing state-of-the-art methods.
  • The proposed method effectively predicts drug-target interactions.

Conclusions:

  • The DTI-CNN method shows enhanced performance over existing approaches.
  • The proposed computational model is well-designed for DTI prediction.
  • This approach offers a promising tool for accelerating drug discovery.